ABC efflux transporters in brain vasculature of Alzheimer's subjects

Multidrug efflux transporters of the ATP-Binding cassette (ABC) family, P-glycoprotein (Pgp), multidrug-resistance associated protein 4 (MRP4) and breast cancer resistance protein (BCRP), located on endothelial cells lining brain vasculature play important roles in limiting movement of substances in...

Full description

Saved in:
Bibliographic Details
Published inBrain research Vol. 1358; pp. 228 - 238
Main Authors Wijesuriya, Hasini C., Bullock, Jocelyn Y., Faull, Richard L.M., Hladky, Stephen B., Barrand, Margery A.
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier B.V 28.10.2010
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Multidrug efflux transporters of the ATP-Binding cassette (ABC) family, P-glycoprotein (Pgp), multidrug-resistance associated protein 4 (MRP4) and breast cancer resistance protein (BCRP), located on endothelial cells lining brain vasculature play important roles in limiting movement of substances into and enhancing their efflux from the brain. Signals from the surrounding brain normally maintain such barrier function but these may become altered in CNS pathologies such as Alzheimer's disease (AD). Previous studies have reported decreases in the glucose transporter, Glut-1, in brain vasculature of AD patients. The present study investigates the status of the multidrug efflux transporters. Sections of frozen brain from hippocampal region obtained from male AD and age-matched non-demented cases were examined for amyloid plaques and Dkk-1 expression and subjected to dual fluorescence immunochemical staining using antibodies against Pgp, BCRP or MRP4 and von Willebrand factor. Protein expression of each transporter was assessed using confocal microscopy, quantifying peak fluorescence values of cross sectional profiles across brain microvessels. Results in brain microvessels revealed expression of Pgp protein to be significantly lower in hippocampal vessels of patients with AD compared to normal individuals whereas that of MRP4 or BCRP protein was not. By contrast, analysis of the sections at protein level via Western blotting or at transcript level by qRT-PCR did not reveal significantly lower expression for either Pgp or BCRP. Such analysis did however reveal higher than normal expression in the AD brains of MRP4, probably due to gliosis, MRP4 being present also in glial cells. ► Do conditions in Alzheimer's brains affect efflux transporters on brain microvessels? ► Immunofluorescent staining for P-glycoprotein, BCRP or MRP4 in AD and normal brains. ► Transporter levels in brain microvessels quantified by confocal microscopy. ► Pgp but not BCRP or MRP4 was significantly lower in hippocampal vessels in AD cases. ► MRP4 at non-vascular sites correlated with increased glial cell number in AD brains.
AbstractList Multidrug efflux transporters of the ATP-Binding cassette (ABC) family, P-glycoprotein (Pgp), multidrug-resistance associated protein 4 (MRP4) and breast cancer resistance protein (BCRP), located on endothelial cells lining brain vasculature play important roles in limiting movement of substances into and enhancing their efflux from the brain. Signals from the surrounding brain normally maintain such barrier function but these may become altered in CNS pathologies such as Alzheimer's disease (AD). Previous studies have reported decreases in the glucose transporter, Glut-1, in brain vasculature of AD patients. The present study investigates the status of the multidrug efflux transporters. Sections of frozen brain from hippocampal region obtained from male AD and age-matched non-demented cases were examined for amyloid plaques and Dkk-1 expression and subjected to dual fluorescence immunochemical staining using antibodies against Pgp, BCRP or MRP4 and von Willebrand factor. Protein expression of each transporter was assessed using confocal microscopy, quantifying peak fluorescence values of cross sectional profiles across brain microvessels. Results in brain microvessels revealed expression of Pgp protein to be significantly lower in hippocampal vessels of patients with AD compared to normal individuals whereas that of MRP4 or BCRP protein was not. By contrast, analysis of the sections at protein level via Western blotting or at transcript level by qRT-PCR did not reveal significantly lower expression for either Pgp or BCRP. Such analysis did however reveal higher than normal expression in the AD brains of MRP4, probably due to gliosis, MRP4 being present also in glial cells. ► Do conditions in Alzheimer's brains affect efflux transporters on brain microvessels? ► Immunofluorescent staining for P-glycoprotein, BCRP or MRP4 in AD and normal brains. ► Transporter levels in brain microvessels quantified by confocal microscopy. ► Pgp but not BCRP or MRP4 was significantly lower in hippocampal vessels in AD cases. ► MRP4 at non-vascular sites correlated with increased glial cell number in AD brains.
Multidrug efflux transporters of the ATP-Binding cassette (ABC) family, P-glycoprotein (Pgp), multidrug-resistance associated protein 4 (MRP4) and breast cancer resistance protein (BCRP), located on endothelial cells lining brain vasculature play important roles in limiting movement of substances into and enhancing their efflux from the brain. Signals from the surrounding brain normally maintain such barrier function but these may become altered in CNS pathologies such as Alzheimer's disease (AD). Previous studies have reported decreases in the glucose transporter, Glut-1, in brain vasculature of AD patients. The present study investigates the status of the multidrug efflux transporters. Sections of frozen brain from hippocampal region obtained from male AD and age-matched non-demented cases were examined for amyloid plaques and Dkk-1 expression and subjected to dual fluorescence immunochemical staining using antibodies against Pgp, BCRP or MRP4 and von Willebrand factor. Protein expression of each transporter was assessed using confocal microscopy, quantifying peak fluorescence values of cross sectional profiles across brain microvessels. Results in brain microvessels revealed expression of Pgp protein to be significantly lower in hippocampal vessels of patients with AD compared to normal individuals whereas that of MRP4 or BCRP protein was not. By contrast, analysis of the sections at protein level via Western blotting or at transcript level by qRT-PCR did not reveal significantly lower expression for either Pgp or BCRP. Such analysis did however reveal higher than normal expression in the AD brains of MRP4, probably due to gliosis, MRP4 being present also in glial cells. a-[ordm Do conditions in Alzheimer's brains affect efflux transporters on brain microvessels? a-[ordm Immunofluorescent staining for P-glycoprotein, BCRP or MRP4 in AD and normal brains. a-[ordm Transporter levels in brain microvessels quantified by confocal microscopy. a-[ordm Pgp but not BCRP or MRP4 was significantly lower in hippocampal vessels in AD cases. a-[ordm MRP4 at non-vascular sites correlated with increased glial cell number in AD brains.
Abstract Multidrug efflux transporters of the ATP-Binding cassette (ABC) family, P-glycoprotein (Pgp), multidrug-resistance associated protein 4 (MRP4) and breast cancer resistance protein (BCRP), located on endothelial cells lining brain vasculature play important roles in limiting movement of substances into and enhancing their efflux from the brain. Signals from the surrounding brain normally maintain such barrier function but these may become altered in CNS pathologies such as Alzheimer's disease (AD). Previous studies have reported decreases in the glucose transporter, Glut-1, in brain vasculature of AD patients. The present study investigates the status of the multidrug efflux transporters. Sections of frozen brain from hippocampal region obtained from male AD and age-matched non-demented cases were examined for amyloid plaques and Dkk-1 expression and subjected to dual fluorescence immunochemical staining using antibodies against Pgp, BCRP or MRP4 and von Willebrand factor. Protein expression of each transporter was assessed using confocal microscopy, quantifying peak fluorescence values of cross sectional profiles across brain microvessels. Results in brain microvessels revealed expression of Pgp protein to be significantly lower in hippocampal vessels of patients with AD compared to normal individuals whereas that of MRP4 or BCRP protein was not. By contrast, analysis of the sections at protein level via Western blotting or at transcript level by qRT-PCR did not reveal significantly lower expression for either Pgp or BCRP. Such analysis did however reveal higher than normal expression in the AD brains of MRP4, probably due to gliosis, MRP4 being present also in glial cells.
Multidrug efflux transporters of the ATP-Binding cassette (ABC) family, P-glycoprotein (Pgp), multidrug-resistance associated protein 4 (MRP4) and breast cancer resistance protein (BCRP), located on endothelial cells lining brain vasculature play important roles in limiting movement of substances into and enhancing their efflux from the brain. Signals from the surrounding brain normally maintain such barrier function but these may become altered in CNS pathologies such as Alzheimer's disease (AD). Previous studies have reported decreases in the glucose transporter, Glut-1, in brain vasculature of AD patients. The present study investigates the status of the multidrug efflux transporters. Sections of frozen brain from hippocampal region obtained from male AD and age-matched non-demented cases were examined for amyloid plaques and Dkk-1 expression and subjected to dual fluorescence immunochemical staining using antibodies against Pgp, BCRP or MRP4 and von Willebrand factor. Protein expression of each transporter was assessed using confocal microscopy, quantifying peak fluorescence values of cross sectional profiles across brain microvessels. Results in brain microvessels revealed expression of Pgp protein to be significantly lower in hippocampal vessels of patients with AD compared to normal individuals whereas that of MRP4 or BCRP protein was not. By contrast, analysis of the sections at protein level via Western blotting or at transcript level by qRT-PCR did not reveal significantly lower expression for either Pgp or BCRP. Such analysis did however reveal higher than normal expression in the AD brains of MRP4, probably due to gliosis, MRP4 being present also in glial cells.
Multidrug efflux transporters of the ATP-Binding cassette (ABC) family, P-glycoprotein (Pgp), multidrug-resistance associated protein 4 (MRP4) and breast cancer resistance protein (BCRP), located on endothelial cells lining brain vasculature play important roles in limiting movement of substances into and enhancing their efflux from the brain. Signals from the surrounding brain normally maintain such barrier function but these may become altered in CNS pathologies such as Alzheimer's disease (AD). Previous studies have reported decreases in the glucose transporter, Glut-1, in brain vasculature of AD patients. The present study investigates the status of the multidrug efflux transporters. Sections of frozen brain from hippocampal region obtained from male AD and age-matched non-demented cases were examined for amyloid plaques and Dkk-1 expression and subjected to dual fluorescence immunochemical staining using antibodies against Pgp, BCRP or MRP4 and von Willebrand factor. Protein expression of each transporter was assessed using confocal microscopy, quantifying peak fluorescence values of cross sectional profiles across brain microvessels. Results in brain microvessels revealed expression of Pgp protein to be significantly lower in hippocampal vessels of patients with AD compared to normal individuals whereas that of MRP4 or BCRP protein was not. By contrast, analysis of the sections at protein level via Western blotting or at transcript level by qRT-PCR did not reveal significantly lower expression for either Pgp or BCRP. Such analysis did however reveal higher than normal expression in the AD brains of MRP4, probably due to gliosis, MRP4 being present also in glial cells.Multidrug efflux transporters of the ATP-Binding cassette (ABC) family, P-glycoprotein (Pgp), multidrug-resistance associated protein 4 (MRP4) and breast cancer resistance protein (BCRP), located on endothelial cells lining brain vasculature play important roles in limiting movement of substances into and enhancing their efflux from the brain. Signals from the surrounding brain normally maintain such barrier function but these may become altered in CNS pathologies such as Alzheimer's disease (AD). Previous studies have reported decreases in the glucose transporter, Glut-1, in brain vasculature of AD patients. The present study investigates the status of the multidrug efflux transporters. Sections of frozen brain from hippocampal region obtained from male AD and age-matched non-demented cases were examined for amyloid plaques and Dkk-1 expression and subjected to dual fluorescence immunochemical staining using antibodies against Pgp, BCRP or MRP4 and von Willebrand factor. Protein expression of each transporter was assessed using confocal microscopy, quantifying peak fluorescence values of cross sectional profiles across brain microvessels. Results in brain microvessels revealed expression of Pgp protein to be significantly lower in hippocampal vessels of patients with AD compared to normal individuals whereas that of MRP4 or BCRP protein was not. By contrast, analysis of the sections at protein level via Western blotting or at transcript level by qRT-PCR did not reveal significantly lower expression for either Pgp or BCRP. Such analysis did however reveal higher than normal expression in the AD brains of MRP4, probably due to gliosis, MRP4 being present also in glial cells.
Author Hladky, Stephen B.
Barrand, Margery A.
Bullock, Jocelyn Y.
Wijesuriya, Hasini C.
Faull, Richard L.M.
Author_xml – sequence: 1
  givenname: Hasini C.
  surname: Wijesuriya
  fullname: Wijesuriya, Hasini C.
  organization: Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1PD, UK
– sequence: 2
  givenname: Jocelyn Y.
  surname: Bullock
  fullname: Bullock, Jocelyn Y.
  organization: Centre for Brain Research and Department of Anatomy with Radiology, University of Auckland, New Zealand
– sequence: 3
  givenname: Richard L.M.
  surname: Faull
  fullname: Faull, Richard L.M.
  organization: Centre for Brain Research and Department of Anatomy with Radiology, University of Auckland, New Zealand
– sequence: 4
  givenname: Stephen B.
  surname: Hladky
  fullname: Hladky, Stephen B.
  organization: Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1PD, UK
– sequence: 5
  givenname: Margery A.
  surname: Barrand
  fullname: Barrand, Margery A.
  email: mb10002@cam.ac.uk
  organization: Department of Pharmacology, University of Cambridge, Tennis Court Road, Cambridge, CB2 1PD, UK
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=23327553$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/20727860$$D View this record in MEDLINE/PubMed
BookMark eNqNkl9v2yAUxdHUak27fYXKL1OfnF3AASxN07LsX6VKfdj2jDC-aHgOzsCu1n36kSbdpD40fUKg3znAOfeUHIUhICHnFOYUqHjdzZtofIiY5gzyIag58OoZmVElWSlYBUdkBgCiVHXNT8hpSl3ecl7Dc3LCQDKpBMzIh-X7VYHO9dPvYowmpM0QR4yp8KG4u6G4MclOvRmniMXgimX_5wf6NcaLVKSp6dCO6QU5dqZP-HK_npHvnz5-W30pr64_X66WV6UVXI6lU7KtnbKArpEtWmPR8rYxylphmRNSNYBC1YohrSStJVdStsCErRynzPAzcrHz3cTh14Rp1GufLPa9CThMSSsqBShZyYOkFIxJtpBPIBdCCIBaZfJ8T07NGlu9iX5t4q2-DzMDr_ZAjsz0LsdpffrPcc7kYsEzJ3acjUNKEd0_hILetqs7fd-u3rarQencbha-eSC0fjSjH0KuzveH5e92cswd3XiMOlmPwWLrY65Rt4M_bPH2gYXtffD5tz_xFlM3TDHkCdBUJ6ZBf91O4HYAKQBV9C6jRwye8oK_267t7w
CODEN BRREAP
CitedBy_id crossref_primary_10_1016_j_biopsych_2017_11_031
crossref_primary_10_3389_fnagi_2024_1368200
crossref_primary_10_1016_j_brainres_2013_04_008
crossref_primary_10_4103_1673_5374_358607
crossref_primary_10_1016_j_expneurol_2025_115189
crossref_primary_10_3390_ijms22073742
crossref_primary_10_1186_2045_8118_8_3
crossref_primary_10_3389_fphar_2018_00658
crossref_primary_10_1177_0271678X18806640
crossref_primary_10_1016_j_pharmthera_2010_12_004
crossref_primary_10_1007_s11095_014_1522_0
crossref_primary_10_1111_nan_12782
crossref_primary_10_3390_pharmaceutics16070948
crossref_primary_10_1016_j_neurobiolaging_2013_09_015
crossref_primary_10_1186_s12987_018_0113_6
crossref_primary_10_1089_neu_2015_3879
crossref_primary_10_2967_jnumed_113_130161
crossref_primary_10_1155_2017_7905486
crossref_primary_10_3389_fimmu_2021_683068
crossref_primary_10_1016_j_xcrm_2024_101609
crossref_primary_10_3390_ijms231810235
crossref_primary_10_1186_s12987_019_0158_1
crossref_primary_10_1007_s12035_020_02211_x
crossref_primary_10_1016_j_addr_2011_11_010
crossref_primary_10_1016_j_nucmedbio_2015_09_001
crossref_primary_10_1080_03602532_2023_2180028
crossref_primary_10_1208_s12248_017_0077_5
crossref_primary_10_1016_j_expneurol_2020_113257
crossref_primary_10_1007_s11095_017_2263_7
crossref_primary_10_1111_febs_15148
crossref_primary_10_1016_j_xphs_2017_01_013
crossref_primary_10_3233_JAD_150350
crossref_primary_10_3390_ijms23031019
crossref_primary_10_1016_j_neuropharm_2017_08_002
crossref_primary_10_1111_jnc_15609
crossref_primary_10_1016_j_pharmr_2025_100052
crossref_primary_10_1002_1873_3468_13951
crossref_primary_10_4155_tde_11_65
crossref_primary_10_1186_1742_2094_9_150
crossref_primary_10_3390_ijms22031231
crossref_primary_10_1055_s_0041_1735541
crossref_primary_10_1186_s12987_023_00466_9
crossref_primary_10_3390_ijms21041505
crossref_primary_10_1016_j_yfrne_2020_100857
crossref_primary_10_1016_j_neuint_2014_05_004
crossref_primary_10_1186_s13550_020_00674_6
crossref_primary_10_1371_journal_pone_0250371
crossref_primary_10_3390_pharmaceutics10030102
crossref_primary_10_1016_j_biomaterials_2020_120461
crossref_primary_10_3389_fnagi_2018_00186
crossref_primary_10_1007_s00401_019_01967_4
crossref_primary_10_1016_j_arcmed_2014_11_018
crossref_primary_10_1016_j_pharmthera_2019_03_009
crossref_primary_10_1016_j_etap_2022_104003
crossref_primary_10_1016_j_arr_2024_102291
crossref_primary_10_1186_s12987_021_00245_4
crossref_primary_10_3390_brainsci10120902
crossref_primary_10_1021_cn300077c
crossref_primary_10_1038_nrd_2015_21
crossref_primary_10_3233_JAD_240212
crossref_primary_10_3390_ijms22042022
crossref_primary_10_1016_j_addr_2011_12_007
crossref_primary_10_1177_0271678X221111602
crossref_primary_10_1124_pharmrev_120_000025
crossref_primary_10_1177_0271678X16660984
crossref_primary_10_1002_jcph_1709
crossref_primary_10_1155_2014_191863
crossref_primary_10_1016_j_brainres_2011_08_044
crossref_primary_10_1523_JNEUROSCI_0350_15_2016
crossref_primary_10_1007_s11095_024_03731_0
crossref_primary_10_1016_j_brainres_2015_07_005
crossref_primary_10_1016_j_pneurobio_2019_101680
crossref_primary_10_3233_JAD_170639
crossref_primary_10_1007_s11095_021_03006_y
crossref_primary_10_1007_s11095_025_03826_2
crossref_primary_10_1038_cddis_2014_258
crossref_primary_10_3390_molecules22101692
crossref_primary_10_3390_ijms21218245
crossref_primary_10_1021_acs_molpharmaceut_4c00633
crossref_primary_10_1002_1873_3468_13982
crossref_primary_10_1093_brain_awac495
crossref_primary_10_18231_j_ijpp_2020_035
crossref_primary_10_1016_j_addr_2022_114282
crossref_primary_10_1186_s12987_023_00470_z
crossref_primary_10_1016_j_xphs_2021_08_013
crossref_primary_10_1016_j_biomaterials_2019_119491
crossref_primary_10_1016_j_ijdevneu_2013_10_005
crossref_primary_10_1016_j_nbd_2022_105741
crossref_primary_10_1002_cpt_435
crossref_primary_10_1016_j_heliyon_2022_e09777
crossref_primary_10_3390_ijms24065438
crossref_primary_10_1016_j_neulet_2013_06_044
crossref_primary_10_3390_ijms22073356
crossref_primary_10_1021_acs_molpharmaceut_1c00549
crossref_primary_10_1146_annurev_cellbio_100617_062608
crossref_primary_10_3390_pharmaceutics14071376
crossref_primary_10_1016_j_pharmthera_2020_107554
crossref_primary_10_1002_cpt_2035
Cites_doi 10.1097/00008571-200210000-00005
10.1007/s00401-009-0522-3
10.1016/j.neuron.2008.01.003
10.1007/s00702-009-0226-9
10.1038/jcbfm.2009.42
10.1016/j.neuroscience.2008.06.015
10.1146/annurev.biochem.67.1.395
10.1111/j.1750-3639.2007.00075.x
10.1073/pnas.0805165106
10.1016/j.parkreldis.2008.11.010
10.1007/s00401-006-0115-3
10.1016/j.bbapap.2009.02.014
10.1016/j.neuroscience.2004.07.051
10.1074/jbc.M100710200
10.1046/j.1471-4159.2001.00113.x
10.1016/j.pharmthera.2009.10.004
10.1038/nrn1824
10.1006/scbi.1997.0068
10.1007/s00401-008-0366-2
10.1111/j.1471-4159.2008.05537.x
10.1523/JNEUROSCI.5103-08.2009
10.1016/0197-4580(95)00021-6
10.1038/sj.tpj.6500413
10.1016/j.toxlet.2010.04.025
10.1016/j.neurobiolaging.2008.05.015
10.1083/jcb.200806024
10.1186/1750-1326-1-13
10.1073/pnas.97.7.3473
10.1016/j.brainres.2008.06.124
10.1016/j.phrs.2009.02.007
10.1523/JNEUROSCI.1381-04.2004
10.1038/cdd.2008.172
10.1038/nn1676
10.2174/156720508785132262
10.1083/jcb.114.5.1059
10.1124/mol.109.061754
10.1172/JCI25247
10.1007/BF00193951
10.1124/pr.107.07109
ContentType Journal Article
Copyright 2010 Elsevier B.V.
Elsevier B.V.
2015 INIST-CNRS
Copyright © 2010 Elsevier B.V. All rights reserved.
Copyright_xml – notice: 2010 Elsevier B.V.
– notice: Elsevier B.V.
– notice: 2015 INIST-CNRS
– notice: Copyright © 2010 Elsevier B.V. All rights reserved.
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7TK
DOI 10.1016/j.brainres.2010.08.034
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Neurosciences Abstracts
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
Neurosciences Abstracts
DatabaseTitleList
Neurosciences Abstracts

MEDLINE
Neurosciences Abstracts

MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 1872-6240
EndPage 238
ExternalDocumentID 20727860
23327553
10_1016_j_brainres_2010_08_034
S0006899310018160
1_s2_0_S0006899310018160
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
--K
--M
-DZ
-~X
.1-
.FO
.~1
0R~
1B1
1P~
1RT
1~.
1~5
23N
4.4
457
4G.
5GY
5RE
5VS
6J9
7-5
71M
8P~
9JM
AABNK
AAEDT
AAEDW
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AATTM
AAXKI
AAXLA
AAXUO
AAYWO
ABCQJ
ABFNM
ABFRF
ABIVO
ABJNI
ABLJU
ABMAC
ABTEW
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACIUM
ACNCT
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
AEBSH
AEFWE
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFPUW
AFRHN
AFTJW
AFXIZ
AGCQF
AGUBO
AGWIK
AGYEJ
AHHHB
AIEXJ
AIIUN
AIKHN
AITUG
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
AXJTR
BKOJK
BLXMC
CS3
DU5
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FIRID
FNPLU
FYGXN
G-Q
HZ~
IHE
J1W
K-O
KOM
L7B
M2V
M41
MO0
MOBAO
N9A
O-L
O9-
OAUVE
OP~
OZT
P-8
P-9
P2P
PC.
Q38
ROL
RPZ
SCC
SDF
SDG
SES
SPCBC
SSN
SSZ
T5K
Z5R
ZGI
~G-
.55
.GJ
41~
53G
AACTN
AAQXK
AAYJJ
ADIYS
AFCTW
AFJKZ
AFKWA
AGHFR
AI.
AJOXV
AMFUW
ASPBG
AVWKF
AZFZN
FEDTE
FGOYB
G-2
GBLVA
HMQ
HVGLF
MVM
PKN
R2-
RIG
SEW
SNS
VH1
WUQ
X7M
XPP
AADPK
AAIAV
ABYKQ
AJBFU
EFLBG
AAYXX
AGQPQ
AGRNS
AIGII
APXCP
BNPGV
CITATION
SSH
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7TK
ID FETCH-LOGICAL-c637t-f87d9f8c0efb7decacec3dba8cc6c2f678b0e68982e1471973877d026c4f312a3
IEDL.DBID .~1
ISSN 0006-8993
1872-6240
IngestDate Fri Jul 11 01:42:03 EDT 2025
Fri Jul 11 10:29:32 EDT 2025
Mon Jul 21 09:37:37 EDT 2025
Mon Jul 21 06:02:38 EDT 2025
Wed Apr 02 07:25:52 EDT 2025
Tue Jul 01 01:21:26 EDT 2025
Thu Apr 24 23:11:53 EDT 2025
Fri Feb 23 02:22:40 EST 2024
Sun Feb 23 10:19:11 EST 2025
Tue Aug 26 16:31:44 EDT 2025
IsPeerReviewed true
IsScholarly true
Keywords P-glycoprotein
BCRP
Alzheimer's disease
MRP4
Blood–brain barrier
Human
Nervous system diseases
Alzheimer disease
Blood―brain barrier
Central nervous system
Glycoprotein
Blood brain barrier
Cerebral disorder
Encephalon
Central nervous system disease
Degenerative disease
ABC transporter
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
CC BY 4.0
Copyright © 2010 Elsevier B.V. All rights reserved.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c637t-f87d9f8c0efb7decacec3dba8cc6c2f678b0e68982e1471973877d026c4f312a3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
PMID 20727860
PQID 756660098
PQPubID 23462
PageCount 11
ParticipantIDs proquest_miscellaneous_817608747
proquest_miscellaneous_762272577
proquest_miscellaneous_756660098
pubmed_primary_20727860
pascalfrancis_primary_23327553
crossref_primary_10_1016_j_brainres_2010_08_034
crossref_citationtrail_10_1016_j_brainres_2010_08_034
elsevier_sciencedirect_doi_10_1016_j_brainres_2010_08_034
elsevier_clinicalkeyesjournals_1_s2_0_S0006899310018160
elsevier_clinicalkey_doi_10_1016_j_brainres_2010_08_034
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2010-10-28
PublicationDateYYYYMMDD 2010-10-28
PublicationDate_xml – month: 10
  year: 2010
  text: 2010-10-28
  day: 28
PublicationDecade 2010
PublicationPlace Amsterdam
PublicationPlace_xml – name: Amsterdam
– name: Netherlands
PublicationTitle Brain research
PublicationTitleAlternate Brain Res
PublicationYear 2010
Publisher Elsevier B.V
Elsevier
Publisher_xml – name: Elsevier B.V
– name: Elsevier
References Miller, Tavares, Johanson, Hovanesian, Donahue, Gonzales, Silverberg, Stopa (bb0115) 2008; 1230
Frankfort, Doodeman, Bakker, Tulner, van Campen, Smits, Beijnen (bb0060) 2006; 1
Leschziner, Andrew, Pirmohamed, Johnson (bb0090) 2007; 7
Zlokovic (bb0200) 2008; 57
Caricasole, Copani, Caraci, Aronica, Rozemuller, Caruso, Storto, Gaviraghi, Terstappen, Nicoletti (bb0025) 2004; 24
Hoffmeyer, Burk, von Richter, Arnold, Brockmoller, Johne, Cascorbi, Gerloff, Roots, Eichelbaum, Brinkmann (bb0075) 2000; 97
Braak, Braak (bb0020) 1995; 16
Liebner, Corada, Bangsow, Babbage, Taddei, Czupalla, Reis, Felici, Wolburg, Fruttiger, Taketo, von Melchner, Plate, Gerhardt, Dejana (bb0095) 2008; 183
Lam, Liu, Lu, Shapiro, Renoir, Sharom, Reiner (bb0100) 2001; 76
Chishti, Yang, Janus, Phinney, Horne, Pearson, Strome, Zuker, Loukides, French, Turner, Lozza, Grilli, Kunicki, Morissette, Paquette, Gervais, Bergeron, Fraser, Carlson, George-Hyslop, Westaway (bb0030) 2001; 276
Schinkel (bb0150) 1997; 8
Tai, Loughlin, Male, Romero (bb0165) 2009; 29
Warren, Zerangue, Woodford, Roberts, Tate, Feng, Li, Feuerstein, Gibbs, Smith, de Morias, Dower, Koller (bb0185) 2009; 59
Ek, Wong, Liddelow, Johansson, Dziegielewska, Saunders (bb0055) 2010; 197
Lim, Kania, Wijesuriya, Chawla, Sethi, Pulaski, Romero, Couraud, Weksler, Hladky, Barrand (bb0105) 2008; 106
Bell, Zlokovic (bb0015) 2009; 118
Vogelgesang, Kuhnke, Jedlitschky, Jucker, Mosyagin, Pahnke, Cascorbi, Kroemer, Walker, Warzok (bb0180) 2006; 112
Nies, Jedlitschky, Konig, Herold-Mende, Steiner, Schmitt, Keppler (bb0120) 2004; 129
Kuhnke, Jedlitschky, Grube, Krohn, Jucker, Mosyagin, Cascorbi, Walker, Kroemer, Warzok, Vogelgesang (bb0085) 2007; 17
Roberts, Black, Raman, Woodford, Zhou, Haggerty, Yan, Cwirla, Grindstaff (bb0135) 2008; 155
Desai, Schneider, Li, Carvey, Hendey (bb0045) 2009; 116
Horwood, Davis (bb0080) 1994; 425
Vogelgesang, Cascorbi, Schroeder, Pahnke, Kroemer, Siegmund, Kunert-Keil, Walker, Warzok (bb0175) 2002; 12
Donahue, Flaherty, Johanson, Duncan, Silverberg, Miller, Tavares, Yang, Wu, Sabo, Hovanesian, Stopa (bb0050) 2006; 112
Daneman, Agalliu, Zhou, Kuhnert, Kuo, Barres (bb0040) 2009; 106
Hartz, Miller, Bauer (bb0070) 2010; 77
Fung, Gottesman (bb0065) 2009; 1794
Sadler (bb0145) 1998; 67
Potschka (bb0130) 2010; 125
Miller, Bauer, Hartz (bb0110) 2008; 60
Xiong, Callaghan, Jones, Bai, Rasquinha, Smith, Pei, Walker, Lue, Stanimirovic, Zhang (bb0195) 2009; 29
Cirrito, Deane, Fagan, Spinner, Parsadanian, Finn, Jiang, Prior, Sagare, Bales, Paul, Zlokovic, Piwnica-Worms, Holtzman (bb0035) 2005; 115
Simpson, Ince, Lace, Forster, Shaw, Matthews, Savva, Brayne, Wharton (bb0155) 2010; 31
Albelda, Muller, Buck, Newman (bb0010) 1991; 114
Pahnke, Wolkenhauer, Krohn, Walker (bb0125) 2008; 5
Thal, Griffin, de Vos, Ghebremedhin (bb0170) 2008; 115
Rodriguez, Olabarria, Chvatal, Verkhratsky (bb0140) 2009; 16
Spudich, Kilic, Xing, Kilic, Rentsch, Wunderli-Allenspach, Bassetti, Hermann (bb0160) 2006; 9
Westerlund, Belin, Anvret, Hakansson, Nissbrandt, Lind, Sydow, Olson, Galter (bb0190) 2009; 15
Abbott, Ronnback, Hansson (bb0005) 2006; 7
Warren (10.1016/j.brainres.2010.08.034_bb0185) 2009; 59
Caricasole (10.1016/j.brainres.2010.08.034_bb0025) 2004; 24
Spudich (10.1016/j.brainres.2010.08.034_bb0160) 2006; 9
Horwood (10.1016/j.brainres.2010.08.034_bb0080) 1994; 425
Rodriguez (10.1016/j.brainres.2010.08.034_bb0140) 2009; 16
Miller (10.1016/j.brainres.2010.08.034_bb0110) 2008; 60
Liebner (10.1016/j.brainres.2010.08.034_bb0095) 2008; 183
Bell (10.1016/j.brainres.2010.08.034_bb0015) 2009; 118
Daneman (10.1016/j.brainres.2010.08.034_bb0040) 2009; 106
Cirrito (10.1016/j.brainres.2010.08.034_bb0035) 2005; 115
Pahnke (10.1016/j.brainres.2010.08.034_bb0125) 2008; 5
Schinkel (10.1016/j.brainres.2010.08.034_bb0150) 1997; 8
Nies (10.1016/j.brainres.2010.08.034_bb0120) 2004; 129
Potschka (10.1016/j.brainres.2010.08.034_bb0130) 2010; 125
Donahue (10.1016/j.brainres.2010.08.034_bb0050) 2006; 112
Hoffmeyer (10.1016/j.brainres.2010.08.034_bb0075) 2000; 97
Kuhnke (10.1016/j.brainres.2010.08.034_bb0085) 2007; 17
Miller (10.1016/j.brainres.2010.08.034_bb0115) 2008; 1230
Westerlund (10.1016/j.brainres.2010.08.034_bb0190) 2009; 15
Desai (10.1016/j.brainres.2010.08.034_bb0045) 2009; 116
Fung (10.1016/j.brainres.2010.08.034_bb0065) 2009; 1794
Roberts (10.1016/j.brainres.2010.08.034_bb0135) 2008; 155
Simpson (10.1016/j.brainres.2010.08.034_bb0155) 2010; 31
Xiong (10.1016/j.brainres.2010.08.034_bb0195) 2009; 29
Leschziner (10.1016/j.brainres.2010.08.034_bb0090) 2007; 7
Thal (10.1016/j.brainres.2010.08.034_bb0170) 2008; 115
Hartz (10.1016/j.brainres.2010.08.034_bb0070) 2010; 77
Lam (10.1016/j.brainres.2010.08.034_bb0100) 2001; 76
Chishti (10.1016/j.brainres.2010.08.034_bb0030) 2001; 276
Abbott (10.1016/j.brainres.2010.08.034_bb0005) 2006; 7
Vogelgesang (10.1016/j.brainres.2010.08.034_bb0180) 2006; 112
Albelda (10.1016/j.brainres.2010.08.034_bb0010) 1991; 114
Zlokovic (10.1016/j.brainres.2010.08.034_bb0200) 2008; 57
Lim (10.1016/j.brainres.2010.08.034_bb0105) 2008; 106
Tai (10.1016/j.brainres.2010.08.034_bb0165) 2009; 29
Ek (10.1016/j.brainres.2010.08.034_bb0055) 2010; 197
Braak (10.1016/j.brainres.2010.08.034_bb0020) 1995; 16
Sadler (10.1016/j.brainres.2010.08.034_bb0145) 1998; 67
Frankfort (10.1016/j.brainres.2010.08.034_bb0060) 2006; 1
Vogelgesang (10.1016/j.brainres.2010.08.034_bb0175) 2002; 12
References_xml – volume: 17
  start-page: 347
  year: 2007
  end-page: 353
  ident: bb0085
  article-title: MDR1-P-Glycoprotein (ABCB1) Mediates Transport of Alzheimer's amyloid-beta peptides—implications for the mechanisms of Abeta clearance at the blood–brain barrier
  publication-title: Brain Pathol.
– volume: 125
  start-page: 118
  year: 2010
  end-page: 127
  ident: bb0130
  article-title: Targeting regulation of ABC efflux transporters in brain diseases: a novel therapeutic approach
  publication-title: Pharmacol. Therap.
– volume: 57
  start-page: 178
  year: 2008
  end-page: 201
  ident: bb0200
  article-title: The blood–brain barrier in health and chronic neurodegenerative disorders
  publication-title: Neuron
– volume: 15
  start-page: 422
  year: 2009
  end-page: 424
  ident: bb0190
  article-title: Association of a polymorphism in the ABCB1 gene with Parkinson's disease
  publication-title: Parkinsonism Relat. Disord.
– volume: 106
  start-page: 641
  year: 2009
  end-page: 646
  ident: bb0040
  article-title: Wnt/beta-catenin signaling is required for CNS, but not non-CNS, angiogenesis
  publication-title: Proc. Natl Acad. Sci. USA
– volume: 76
  start-page: 1121
  year: 2001
  end-page: 1128
  ident: bb0100
  article-title: beta-Amyloid efflux mediated by p-glycoprotein
  publication-title: J. Neurochem.
– volume: 59
  start-page: 404
  year: 2009
  end-page: 413
  ident: bb0185
  article-title: Comparative gene expression profiles of ABC transporters in brain microvessel endothelial cells and brain in five species including human
  publication-title: Pharmacol. Res.
– volume: 112
  start-page: 355
  year: 2006
  end-page: 367
  ident: bb0180
  article-title: P-glycoprotein (ABCB1) mediates transport of Alzheimer's beta-amyloid peptides
  publication-title: Acta Neuropathol.
– volume: 1
  start-page: 13
  year: 2006
  ident: bb0060
  article-title: ABCB1 genotypes and haplotypes in patients with dementia and age-matched non-demented control patients
  publication-title: Mol. Neurodegener.
– volume: 97
  start-page: 3473
  year: 2000
  end-page: 3478
  ident: bb0075
  article-title: Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo
  publication-title: Proc. Natl Acad. Sci. USA
– volume: 77
  start-page: 715
  year: 2010
  end-page: 723
  ident: bb0070
  article-title: Restoring blood–brain barrier P-glycoprotein reduces brain amyloid-β in a mouse model of Alzheimer's disease
  publication-title: Molec. Pharmacol.
– volume: 197
  start-page: 51
  year: 2010
  end-page: 59
  ident: bb0055
  article-title: Efflux mechanisms at the developing brain barriers: ABC-transporters in the fetal and post-natal rat
  publication-title: Toxicol. Lett.
– volume: 118
  start-page: 103
  year: 2009
  end-page: 113
  ident: bb0015
  article-title: Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer's disease
  publication-title: Acta Neuropathol.
– volume: 60
  start-page: 196
  year: 2008
  end-page: 209
  ident: bb0110
  article-title: Modulation of P-glycoprotein at the blood–brain barrier: opportunities to improve central nervous system pharmacotherapy
  publication-title: Pharmacol. Rev.
– volume: 115
  start-page: 3285
  year: 2005
  end-page: 3290
  ident: bb0035
  article-title: P-glycoprotein deficiency at the blood–brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model
  publication-title: J. Clin. Invest.
– volume: 183
  start-page: 409
  year: 2008
  end-page: 417
  ident: bb0095
  article-title: Wnt/beta-catenin signaling controls development of the blood–brain barrier
  publication-title: J. Cell Biol.
– volume: 29
  start-page: 5463
  year: 2009
  end-page: 5475
  ident: bb0195
  article-title: ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood–brain barrier for Aβ
  publication-title: J. Neurosci.
– volume: 5
  start-page: 396
  year: 2008
  end-page: 405
  ident: bb0125
  article-title: Clinico-pathologic function of cerebral ABC transporters—implications for the pathogenesis of Alzheimer's disease
  publication-title: Curr. Alzheimer Res.
– volume: 16
  start-page: 378
  year: 2009
  end-page: 385
  ident: bb0140
  article-title: Astroglia in dementia and Alzheimer's disease
  publication-title: Cell Death Different.
– volume: 129
  start-page: 349
  year: 2004
  end-page: 360
  ident: bb0120
  article-title: Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain
  publication-title: Neurosci.
– volume: 8
  start-page: 161
  year: 1997
  end-page: 170
  ident: bb0150
  article-title: The physiological function of drug-transporting P-glycoproteins
  publication-title: Semin. Cancer Biol.
– volume: 276
  start-page: 21562
  year: 2001
  end-page: 21570
  ident: bb0030
  article-title: Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695
  publication-title: J. Biol. Chem.
– volume: 116
  start-page: 587
  year: 2009
  end-page: 597
  ident: bb0045
  article-title: Evidence of angiogenic vessels in Alzheimer's disease
  publication-title: J. Neural Trans.
– volume: 9
  start-page: 487
  year: 2006
  end-page: 488
  ident: bb0160
  article-title: Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia
  publication-title: Nat. Neurosci.
– volume: 112
  start-page: 405
  year: 2006
  end-page: 415
  ident: bb0050
  article-title: RAGE, LRP-1, and amyloid disease
  publication-title: Acta Neuropathol.
– volume: 7
  start-page: 154
  year: 2007
  end-page: 179
  ident: bb0090
  article-title: ABCB1 genotype and PGP expression, function and therapeutic drug response: a critical review and recommendations for future research
  publication-title: Pharmacogenom. J.
– volume: 12
  start-page: 535
  year: 2002
  end-page: 541
  ident: bb0175
  article-title: Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans
  publication-title: Pharmacogenetics
– volume: 1794
  start-page: 860
  year: 2009
  end-page: 871
  ident: bb0065
  article-title: A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function
  publication-title: Biochim. Biophys. Acta
– volume: 425
  start-page: 69
  year: 1994
  end-page: 72
  ident: bb0080
  article-title: Immunolabelling of hippocampal microvessel glucose transporter protein is reduced in Alzheimer's disease
  publication-title: Virchows Arch.
– volume: 67
  start-page: 395
  year: 1998
  end-page: 424
  ident: bb0145
  article-title: Biochemistry and genetics of von Willebrand factor
  publication-title: Annu. Rev. Biochem.
– volume: 29
  start-page: 1079
  year: 2009
  end-page: 1083
  ident: bb0165
  article-title: P-glycoprotein and breast cancer resistance protein restrict apical-to-basolateral permeability of human brain endothelium to amyloid-beta
  publication-title: J. Cereb. Blood Flow Metab.
– volume: 24
  start-page: 6021
  year: 2004
  end-page: 6027
  ident: bb0025
  article-title: Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer's brain
  publication-title: J. Neurosci.
– volume: 114
  start-page: 1059
  year: 1991
  end-page: 1068
  ident: bb0010
  article-title: Molecular and cellular properties of PECAM-1 (endoCAM/CD31): a novel vascular cell-cell adhesion molecule
  publication-title: J. Cell Biol.
– volume: 16
  start-page: 271
  year: 1995
  end-page: 284
  ident: bb0020
  article-title: Staging of Alzheimer's disease-related neurofibrillary changes
  publication-title: Neurobiol. Aging
– volume: 7
  start-page: 41
  year: 2006
  end-page: 53
  ident: bb0005
  article-title: Astrocyte–endothelial interactions at the blood–brain barrier
  publication-title: Nat. Rev. Neurosci.
– volume: 106
  start-page: 1855
  year: 2008
  end-page: 1865
  ident: bb0105
  article-title: Activation of beta-catenin signalling by GSK-3 inhibition increases p-glycoprotein expression in brain endothelial cells
  publication-title: J. Neurochem.
– volume: 1230
  start-page: 273
  year: 2008
  end-page: 280
  ident: bb0115
  article-title: Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's disease
  publication-title: Brain Res.
– volume: 31
  start-page: 578
  year: 2010
  end-page: 590
  ident: bb0155
  article-title: Astrocyte phenotypes in relation to Alzheimer-type pathology in the ageing brain
  publication-title: Neurobiol. Aging
– volume: 115
  start-page: 599
  year: 2008
  end-page: 609
  ident: bb0170
  article-title: Cerebral amyloid angiopathy and its relationship to Alzheimer's disease
  publication-title: Acta Neuropathol.
– volume: 155
  start-page: 423
  year: 2008
  end-page: 438
  ident: bb0135
  article-title: Subcellular localization of transporters along the rat blood–brain barrier and blood–cerebral–spinal fluid barrier by in vivo biotinylation
  publication-title: Neurosci.
– volume: 12
  start-page: 535
  year: 2002
  ident: 10.1016/j.brainres.2010.08.034_bb0175
  article-title: Deposition of Alzheimer's beta-amyloid is inversely correlated with P-glycoprotein expression in the brains of elderly non-demented humans
  publication-title: Pharmacogenetics
  doi: 10.1097/00008571-200210000-00005
– volume: 118
  start-page: 103
  year: 2009
  ident: 10.1016/j.brainres.2010.08.034_bb0015
  article-title: Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer's disease
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-009-0522-3
– volume: 57
  start-page: 178
  year: 2008
  ident: 10.1016/j.brainres.2010.08.034_bb0200
  article-title: The blood–brain barrier in health and chronic neurodegenerative disorders
  publication-title: Neuron
  doi: 10.1016/j.neuron.2008.01.003
– volume: 116
  start-page: 587
  year: 2009
  ident: 10.1016/j.brainres.2010.08.034_bb0045
  article-title: Evidence of angiogenic vessels in Alzheimer's disease
  publication-title: J. Neural Trans.
  doi: 10.1007/s00702-009-0226-9
– volume: 29
  start-page: 1079
  year: 2009
  ident: 10.1016/j.brainres.2010.08.034_bb0165
  article-title: P-glycoprotein and breast cancer resistance protein restrict apical-to-basolateral permeability of human brain endothelium to amyloid-beta
  publication-title: J. Cereb. Blood Flow Metab.
  doi: 10.1038/jcbfm.2009.42
– volume: 155
  start-page: 423
  year: 2008
  ident: 10.1016/j.brainres.2010.08.034_bb0135
  article-title: Subcellular localization of transporters along the rat blood–brain barrier and blood–cerebral–spinal fluid barrier by in vivo biotinylation
  publication-title: Neurosci.
  doi: 10.1016/j.neuroscience.2008.06.015
– volume: 67
  start-page: 395
  year: 1998
  ident: 10.1016/j.brainres.2010.08.034_bb0145
  article-title: Biochemistry and genetics of von Willebrand factor
  publication-title: Annu. Rev. Biochem.
  doi: 10.1146/annurev.biochem.67.1.395
– volume: 17
  start-page: 347
  year: 2007
  ident: 10.1016/j.brainres.2010.08.034_bb0085
  article-title: MDR1-P-Glycoprotein (ABCB1) Mediates Transport of Alzheimer's amyloid-beta peptides—implications for the mechanisms of Abeta clearance at the blood–brain barrier
  publication-title: Brain Pathol.
  doi: 10.1111/j.1750-3639.2007.00075.x
– volume: 106
  start-page: 641
  year: 2009
  ident: 10.1016/j.brainres.2010.08.034_bb0040
  article-title: Wnt/beta-catenin signaling is required for CNS, but not non-CNS, angiogenesis
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.0805165106
– volume: 15
  start-page: 422
  year: 2009
  ident: 10.1016/j.brainres.2010.08.034_bb0190
  article-title: Association of a polymorphism in the ABCB1 gene with Parkinson's disease
  publication-title: Parkinsonism Relat. Disord.
  doi: 10.1016/j.parkreldis.2008.11.010
– volume: 112
  start-page: 405
  year: 2006
  ident: 10.1016/j.brainres.2010.08.034_bb0050
  article-title: RAGE, LRP-1, and amyloid disease
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-006-0115-3
– volume: 1794
  start-page: 860
  year: 2009
  ident: 10.1016/j.brainres.2010.08.034_bb0065
  article-title: A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein function
  publication-title: Biochim. Biophys. Acta
  doi: 10.1016/j.bbapap.2009.02.014
– volume: 129
  start-page: 349
  year: 2004
  ident: 10.1016/j.brainres.2010.08.034_bb0120
  article-title: Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain
  publication-title: Neurosci.
  doi: 10.1016/j.neuroscience.2004.07.051
– volume: 276
  start-page: 21562
  year: 2001
  ident: 10.1016/j.brainres.2010.08.034_bb0030
  article-title: Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695
  publication-title: J. Biol. Chem.
  doi: 10.1074/jbc.M100710200
– volume: 76
  start-page: 1121
  year: 2001
  ident: 10.1016/j.brainres.2010.08.034_bb0100
  article-title: beta-Amyloid efflux mediated by p-glycoprotein
  publication-title: J. Neurochem.
  doi: 10.1046/j.1471-4159.2001.00113.x
– volume: 125
  start-page: 118
  year: 2010
  ident: 10.1016/j.brainres.2010.08.034_bb0130
  article-title: Targeting regulation of ABC efflux transporters in brain diseases: a novel therapeutic approach
  publication-title: Pharmacol. Therap.
  doi: 10.1016/j.pharmthera.2009.10.004
– volume: 7
  start-page: 41
  year: 2006
  ident: 10.1016/j.brainres.2010.08.034_bb0005
  article-title: Astrocyte–endothelial interactions at the blood–brain barrier
  publication-title: Nat. Rev. Neurosci.
  doi: 10.1038/nrn1824
– volume: 8
  start-page: 161
  year: 1997
  ident: 10.1016/j.brainres.2010.08.034_bb0150
  article-title: The physiological function of drug-transporting P-glycoproteins
  publication-title: Semin. Cancer Biol.
  doi: 10.1006/scbi.1997.0068
– volume: 115
  start-page: 599
  year: 2008
  ident: 10.1016/j.brainres.2010.08.034_bb0170
  article-title: Cerebral amyloid angiopathy and its relationship to Alzheimer's disease
  publication-title: Acta Neuropathol.
  doi: 10.1007/s00401-008-0366-2
– volume: 106
  start-page: 1855
  year: 2008
  ident: 10.1016/j.brainres.2010.08.034_bb0105
  article-title: Activation of beta-catenin signalling by GSK-3 inhibition increases p-glycoprotein expression in brain endothelial cells
  publication-title: J. Neurochem.
  doi: 10.1111/j.1471-4159.2008.05537.x
– volume: 29
  start-page: 5463
  year: 2009
  ident: 10.1016/j.brainres.2010.08.034_bb0195
  article-title: ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood–brain barrier for Aβ1–40 peptides
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.5103-08.2009
– volume: 16
  start-page: 271
  year: 1995
  ident: 10.1016/j.brainres.2010.08.034_bb0020
  article-title: Staging of Alzheimer's disease-related neurofibrillary changes
  publication-title: Neurobiol. Aging
  doi: 10.1016/0197-4580(95)00021-6
– volume: 7
  start-page: 154
  year: 2007
  ident: 10.1016/j.brainres.2010.08.034_bb0090
  article-title: ABCB1 genotype and PGP expression, function and therapeutic drug response: a critical review and recommendations for future research
  publication-title: Pharmacogenom. J.
  doi: 10.1038/sj.tpj.6500413
– volume: 197
  start-page: 51
  issue: 1
  year: 2010
  ident: 10.1016/j.brainres.2010.08.034_bb0055
  article-title: Efflux mechanisms at the developing brain barriers: ABC-transporters in the fetal and post-natal rat
  publication-title: Toxicol. Lett.
  doi: 10.1016/j.toxlet.2010.04.025
– volume: 112
  start-page: 355
  year: 2006
  ident: 10.1016/j.brainres.2010.08.034_bb0180
  article-title: P-glycoprotein (ABCB1) mediates transport of Alzheimer's beta-amyloid peptides
  publication-title: Acta Neuropathol.
– volume: 31
  start-page: 578
  year: 2010
  ident: 10.1016/j.brainres.2010.08.034_bb0155
  article-title: Astrocyte phenotypes in relation to Alzheimer-type pathology in the ageing brain
  publication-title: Neurobiol. Aging
  doi: 10.1016/j.neurobiolaging.2008.05.015
– volume: 183
  start-page: 409
  year: 2008
  ident: 10.1016/j.brainres.2010.08.034_bb0095
  article-title: Wnt/beta-catenin signaling controls development of the blood–brain barrier
  publication-title: J. Cell Biol.
  doi: 10.1083/jcb.200806024
– volume: 1
  start-page: 13
  year: 2006
  ident: 10.1016/j.brainres.2010.08.034_bb0060
  article-title: ABCB1 genotypes and haplotypes in patients with dementia and age-matched non-demented control patients
  publication-title: Mol. Neurodegener.
  doi: 10.1186/1750-1326-1-13
– volume: 97
  start-page: 3473
  year: 2000
  ident: 10.1016/j.brainres.2010.08.034_bb0075
  article-title: Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo
  publication-title: Proc. Natl Acad. Sci. USA
  doi: 10.1073/pnas.97.7.3473
– volume: 1230
  start-page: 273
  year: 2008
  ident: 10.1016/j.brainres.2010.08.034_bb0115
  article-title: Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's disease
  publication-title: Brain Res.
  doi: 10.1016/j.brainres.2008.06.124
– volume: 59
  start-page: 404
  year: 2009
  ident: 10.1016/j.brainres.2010.08.034_bb0185
  article-title: Comparative gene expression profiles of ABC transporters in brain microvessel endothelial cells and brain in five species including human
  publication-title: Pharmacol. Res.
  doi: 10.1016/j.phrs.2009.02.007
– volume: 24
  start-page: 6021
  year: 2004
  ident: 10.1016/j.brainres.2010.08.034_bb0025
  article-title: Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is associated with neuronal degeneration in Alzheimer's brain
  publication-title: J. Neurosci.
  doi: 10.1523/JNEUROSCI.1381-04.2004
– volume: 16
  start-page: 378
  year: 2009
  ident: 10.1016/j.brainres.2010.08.034_bb0140
  article-title: Astroglia in dementia and Alzheimer's disease
  publication-title: Cell Death Different.
  doi: 10.1038/cdd.2008.172
– volume: 9
  start-page: 487
  year: 2006
  ident: 10.1016/j.brainres.2010.08.034_bb0160
  article-title: Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia
  publication-title: Nat. Neurosci.
  doi: 10.1038/nn1676
– volume: 5
  start-page: 396
  year: 2008
  ident: 10.1016/j.brainres.2010.08.034_bb0125
  article-title: Clinico-pathologic function of cerebral ABC transporters—implications for the pathogenesis of Alzheimer's disease
  publication-title: Curr. Alzheimer Res.
  doi: 10.2174/156720508785132262
– volume: 114
  start-page: 1059
  year: 1991
  ident: 10.1016/j.brainres.2010.08.034_bb0010
  article-title: Molecular and cellular properties of PECAM-1 (endoCAM/CD31): a novel vascular cell-cell adhesion molecule
  publication-title: J. Cell Biol.
  doi: 10.1083/jcb.114.5.1059
– volume: 77
  start-page: 715
  year: 2010
  ident: 10.1016/j.brainres.2010.08.034_bb0070
  article-title: Restoring blood–brain barrier P-glycoprotein reduces brain amyloid-β in a mouse model of Alzheimer's disease
  publication-title: Molec. Pharmacol.
  doi: 10.1124/mol.109.061754
– volume: 115
  start-page: 3285
  year: 2005
  ident: 10.1016/j.brainres.2010.08.034_bb0035
  article-title: P-glycoprotein deficiency at the blood–brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model
  publication-title: J. Clin. Invest.
  doi: 10.1172/JCI25247
– volume: 425
  start-page: 69
  year: 1994
  ident: 10.1016/j.brainres.2010.08.034_bb0080
  article-title: Immunolabelling of hippocampal microvessel glucose transporter protein is reduced in Alzheimer's disease
  publication-title: Virchows Arch.
  doi: 10.1007/BF00193951
– volume: 60
  start-page: 196
  year: 2008
  ident: 10.1016/j.brainres.2010.08.034_bb0110
  article-title: Modulation of P-glycoprotein at the blood–brain barrier: opportunities to improve central nervous system pharmacotherapy
  publication-title: Pharmacol. Rev.
  doi: 10.1124/pr.107.07109
SSID ssj0003390
Score 2.360444
Snippet Multidrug efflux transporters of the ATP-Binding cassette (ABC) family, P-glycoprotein (Pgp), multidrug-resistance associated protein 4 (MRP4) and breast...
Abstract Multidrug efflux transporters of the ATP-Binding cassette (ABC) family, P-glycoprotein (Pgp), multidrug-resistance associated protein 4 (MRP4) and...
SourceID proquest
pubmed
pascalfrancis
crossref
elsevier
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 228
SubjectTerms Adult and adolescent clinical studies
Aged
Aged, 80 and over
Alzheimer Disease - pathology
Alzheimer's disease
Amyloid - metabolism
ATP Binding Cassette Transporter, Sub-Family G, Member 2
ATP-Binding Cassette Transporters - genetics
ATP-Binding Cassette Transporters - metabolism
ATP-Binding Cassette, Sub-Family B, Member 1 - metabolism
BCRP
Biological and medical sciences
Blood–brain barrier
Brain - pathology
Case-Control Studies
Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
Endothelial Cells - metabolism
Glial Fibrillary Acidic Protein - metabolism
Humans
Intercellular Signaling Peptides and Proteins - metabolism
Male
Medical sciences
Microvessels - metabolism
Middle Aged
MRP4
Multidrug Resistance-Associated Proteins - metabolism
Neoplasm Proteins - metabolism
Neurology
Organic mental disorders. Neuropsychology
P-glycoprotein
Plaque, Amyloid - pathology
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
von Willebrand Factor - genetics
von Willebrand Factor - metabolism
Title ABC efflux transporters in brain vasculature of Alzheimer's subjects
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0006899310018160
https://www.clinicalkey.es/playcontent/1-s2.0-S0006899310018160
https://dx.doi.org/10.1016/j.brainres.2010.08.034
https://www.ncbi.nlm.nih.gov/pubmed/20727860
https://www.proquest.com/docview/756660098
https://www.proquest.com/docview/762272577
https://www.proquest.com/docview/817608747
Volume 1358
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR1di9QwMBzniyCinh_1Y8mD6FN30yRt0se6eqxfh4gH9xaaNME99rrLZhfUB3-7kzbd85BVUSgUSqZNpvOdmQxCT53g8FtNnnIO3MRLLVINZmxqjRSSBRO6a8ny_qSYnfI3Z_nZAZoOtTAhrTLK_l6md9I6PplEbE5W83mo8SUFeAshQg1qqgh-O-ciUPn4-2WaB2N9nCV4zmH0T1XC52Md2jCAWxtTvOSYML5PQd1Y1R7Q5vp-F_sN0k4xHd9CN6NFiat-0rfRgW3voKOqBW_64it-hrsczy54foReVi-m2Dq32H7Bm92x5muP5y3uZoljZmrYV8BLh6vFt892fmHXzz32Wx2CNv4uOj1-9Wk6S2MfhdQUTGxSJ0VTOmmIdVo01tTGGtboWhpTGOpAXWliAZWS2gx0VSmYFKIB58xwxzJas3vosF229gHCpOFcg8WY54LynDRlVoPqy7Sh0jTw2gTlA_KUiYeMh14XCzVkk52rAekqIF2FJpiMJ2iyg1v1x2z8EUIM_0YNRaQg9hRogn-DtD5yr1eZ8lQR9QuFJajcQV4h0r_66ugKAe2WSRmjIs9ZgvBAUQpYPOzb1K1dbr0SYHIX4eDX3wwpKBUgfcX-ITITBZHgPSbofk-vl1MgYMXKgjz8j_U9Qte7xAq4qHyMDjfrrX0C9tpGjzqGHKFr1fTjuw_h_vrt7OQH8-tA3A
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR1Nb9Mw1JrGASSEgPERPoYPCE5pHduxnWMpTAW2nTZpNyt2bK1Tl1ZNK7Ed-O08J07HhAoIpJwiv8R-fp_2-0DorZccttXmKefATbwwMjVgxqbOKqlYMKHblixHx2Jyyr-c5Wc7aNznwoSwyij7O5neSuv4ZhixOVxMpyHHlwjwFsIJNagpAX77HQ7sG9oYDL7fxHkw1h20BNc5DP8pTfhiYEIfBvBrY4yXGhDGt2mo-4uyAbz5ruHFdou01UwHD9GDaFLiUTfrR2jH1Y_R3qgGd_ryCr_DbZBne3q-hz6OPoyx8362_oZXm7rmywZPa9zOEsfQ1HCxgOcej2bX52566ZbvG9ysTTi1aZ6g04NPJ-NJGhsppFYwuUq9klXhlSXOG1k5W1pnWWVKZa2w1IO-MsQBLhV1GSirQjIlZQXemeWeZbRkT9FuPa_dc4RJxbkBkzHPJeU5qYqsBN2XGUuVreCzCcp75Gkbq4yHZhcz3YeTXege6TogXYcumIwnaLiBW3R1Nv4IIfu90X0WKcg9Darg3yBdE9m30ZluqCb6FxJLULGBvEWlf_XX_VsEtFkmZYzKPGcJwj1FaeDxcHFT1m6-brQEm1uEyq-_GSIolSB-5fYhKpOCKHAfE_Sso9ebKRAwY5UgL_5jfW_Q3cnJ0aE-_Hz89SW610ZZwEPVK7S7Wq7dazDeVma_Zc4f39JA1Q
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=ABC+efflux+transporters+in+brain+vasculature+of+Alzheimer%27s+subjects&rft.jtitle=Brain+research&rft.au=Wijesuriya%2C+Hasini+C.&rft.au=Bullock%2C+Jocelyn+Y.&rft.au=Faull%2C+Richard+L.M.&rft.au=Hladky%2C+Stephen+B.&rft.date=2010-10-28&rft.pub=Elsevier+B.V&rft.issn=0006-8993&rft.eissn=1872-6240&rft.volume=1358&rft.spage=228&rft.epage=238&rft_id=info:doi/10.1016%2Fj.brainres.2010.08.034&rft.externalDocID=S0006899310018160
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00068993%2FS0006899310X00476%2Fcov150h.gif